Thursday, October 14, 2021 11:06:03 AM
Recent APRE News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 10:01:02 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/05/2024 05:15:27 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 09:26:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/26/2024 12:13:27 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 01/26/2024 11:03:59 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 09:16:01 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 11/09/2023 09:20:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 09:15:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:10:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2023 09:29:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/13/2023 11:31:14 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/11/2023 12:30:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/25/2023 01:52:29 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/25/2023 01:50:02 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/25/2023 01:48:22 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/24/2023 12:00:28 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 11:39:02 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/10/2023 11:36:21 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 07/11/2023 11:30:29 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/05/2023 08:01:07 PM
- Aprea Therapeutics to Present at Maxim Virtual Healthcare Conference • GlobeNewswire Inc. • 06/14/2023 12:00:00 PM
- Aprea Therapeutics to Present at BIO International Convention • GlobeNewswire Inc. • 05/30/2023 12:30:00 PM
- Aprea Therapeutics Reports First Quarter 2023 Financial Results and Provides Update on Business Operations • GlobeNewswire Inc. • 05/15/2023 08:05:00 PM
- Aprea Therapeutics Appoints Gabriela Gruia, M.D. to Board of Directors • GlobeNewswire Inc. • 05/08/2023 12:00:00 PM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM
Kona Gold Beverages, Inc. Acquires Surge Distribution LLC from Loud Beverage Group, Inc. (LBEV) • KGKG • Apr 16, 2024 8:30 AM